Published online Sep 19, 2023. doi: 10.5498/wjp.v13.i9.607
Peer-review started: June 8, 2023
First decision: July 19, 2023
Revised: July 25, 2023
Accepted: August 1, 2023
Article in press: August 1, 2023
Published online: September 19, 2023
Processing time: 99 Days and 6.8 Hours
Deep transcranial magnetic stimulation (DTMS) is a new non-invasive neuromodulation technique based on repetitive transcranial magnetic stimulation tech-nology. The new H-coil has significant advantages in the treatment and mechanism research of psychiatric and neurological disorders. This is due to its deep stimulation site and wide range of action. This paper reviews the clinical progress of DTMS in psychiatric and neurological disorders such as Parkinson’s disease, Alzheimer’s disease, post-stroke motor dysfunction, aphasia, and other neurological disorders, as well as anxiety, depression, and schizophrenia.
Core Tip: Deep transcranial magnetic stimulation as a novel non-invasive neuromodulation technique has been reported to be applied in clinical psychiatric and neurological disorders. The potential clinical efficacy and safety of this technique in each disorder and the mechanisms behind them need to be further summarized and sorted out, and the direction of future development needs to be more clearly defined.
